iShares Biotechnology ETF (NASDAQ:IBB) Shares Purchased by Transcend Capital Advisors LLC

Transcend Capital Advisors LLC raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,975 shares of the financial services provider’s stock after buying an additional 497 shares during the period. Transcend Capital Advisors LLC’s holdings in iShares Biotechnology ETF were worth $1,491,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Glass Jacobson Investment Advisors llc increased its stake in iShares Biotechnology ETF by 150.6% during the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after buying an additional 122 shares during the period. Values First Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $43,000. Horizon Bancorp Inc. IN acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $44,000. Tennessee Valley Asset Management Partners acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $44,000. Finally, Column Capital Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $49,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB traded up $0.82 during mid-day trading on Friday, hitting $126.49. The company’s stock had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. The firm has a 50-day moving average price of $134.27 and a 200 day moving average price of $129.74. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 annualized dividend and a dividend yield of 0.40%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.